Nigeria eases imports of antiretrovirals

1 May 2001

As part of Nigeria's new emergency plan of action to combat the HIV/AIDSepidemic, the federal government is to waive import duties on antiretroviral drug treatments, the country's President, Olusegun Obasanjo has announced.

Speaking at the the first African HIV/AIDS summit, Pres Obasanjo said that, under the emergency plan, generic drugs will be made accessible and affordable to HIV/AIDS patients, and added that big pharmaceutical companies are ready to help in this initiative, reports the Xinhua news agency.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight